195 related articles for article (PubMed ID: 22542366)
1. Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: a randomized controlled trial.
Brito MB; Ferriani RA; Meijers JC; Garcia AA; Quintana SM; Silva de Sá MF; Vieira CS
Thromb Res; 2012 Sep; 130(3):355-60. PubMed ID: 22542366
[TBL] [Abstract][Full Text] [Related]
2. Use of the etonogestrel-releasing implant is associated with hypoactivation of the coagulation cascade.
Vieira CS; Ferriani RA; Garcia AA; Pintão MC; Azevedo GD; Gomes MK; Silva-de-Sá MF
Hum Reprod; 2007 Aug; 22(8):2196-201. PubMed ID: 17569674
[TBL] [Abstract][Full Text] [Related]
3. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study.
Brito MB; Ferriani RA; Quintana SM; Yazlle ME; Silva de Sá MF; Vieira CS
Contraception; 2009 Dec; 80(6):519-26. PubMed ID: 19913145
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the hemostatic effects of a levonorgestrel-releasing intrauterine system and leuprolide acetate in women with endometriosis: a randomized clinical trial.
Yamaguti EM; Brito MB; Ferriani RA; Garcia AA; Rosa-e-Silva JC; Vieira CS
Thromb Res; 2014 Dec; 134(6):1193-7. PubMed ID: 25283586
[TBL] [Abstract][Full Text] [Related]
5. Immediate postpartum initiation of etonogestrel-releasing implant: A randomized controlled trial on breastfeeding impact.
Braga GC; Ferriolli E; Quintana SM; Ferriani RA; Pfrimer K; Vieira CS
Contraception; 2015 Dec; 92(6):536-42. PubMed ID: 26209863
[TBL] [Abstract][Full Text] [Related]
6. Hemostasis during normal pregnancy and puerperium.
Hellgren M
Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
[TBL] [Abstract][Full Text] [Related]
7. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
[TBL] [Abstract][Full Text] [Related]
8. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
[TBL] [Abstract][Full Text] [Related]
9. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
[TBL] [Abstract][Full Text] [Related]
10. Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial.
Vieira CS; de Nadai MN; de Melo Pereira do Carmo LS; Braga GC; Infante BF; Stifani BM; Ferriani RA; Quintana SM
Contraception; 2019 Oct; 100(4):258-263. PubMed ID: 31145885
[TBL] [Abstract][Full Text] [Related]
11. Etonogestrel implant in postpartum adolescents: bleeding pattern, efficacy and discontinuation rate.
Guazzelli CA; de Queiroz FT; Barbieri M; Torloni MR; de Araujo FF
Contraception; 2010 Sep; 82(3):256-9. PubMed ID: 20705154
[TBL] [Abstract][Full Text] [Related]
12. Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial.
Johnson JV; Lowell J; Badger GJ; Rosing J; Tchaikovski S; Cushman M
Obstet Gynecol; 2008 Feb; 111(2 Pt 1):278-84. PubMed ID: 18238963
[TBL] [Abstract][Full Text] [Related]
13. Acceptability of the levonorgestrel releasing-intrauterine system and etonogestrel implant: one-year results of an observational study.
Short M; Dallay D; Omokanye S; Hanisch JU; Inki P
Eur J Contracept Reprod Health Care; 2012 Feb; 17(1):79-88. PubMed ID: 22200172
[TBL] [Abstract][Full Text] [Related]
14. [Hemostatic balance during treatment with the newest contraceptives].
Petersen KR; Skouby SO; Sidelmann J; Jespersen J
Ugeskr Laeger; 1994 Jan; 156(2):187-90. PubMed ID: 8296409
[TBL] [Abstract][Full Text] [Related]
15. Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.
Wiegratz I; Stahlberg S; Manthey T; Sänger N; Mittmann K; Lange E; Mellinger U; Kuhl H
Contraception; 2008 Nov; 78(5):384-91. PubMed ID: 18929735
[TBL] [Abstract][Full Text] [Related]
16. Association of Immediate Postpartum Etonogestrel Implant Insertion and Venous Thromboembolism.
Floyd JL; Beasley AD; Swaim LS; Turrentine MA; Nijjar JB
Obstet Gynecol; 2020 Jun; 135(6):1275-1280. PubMed ID: 32459418
[TBL] [Abstract][Full Text] [Related]
17. Long acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting.
Tocce K; Sheeder J; Python J; Teal SB
J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):59-63. PubMed ID: 22051792
[TBL] [Abstract][Full Text] [Related]
18. Immediate postpartum etonogestrel implant: a contraception option with long-term continuation.
Wilson S; Tennant C; Sammel MD; Schreiber C
Contraception; 2014 Sep; 90(3):259-64. PubMed ID: 24993485
[TBL] [Abstract][Full Text] [Related]
19. The effect of levenogesterol (Norplant) contraception on coagulation as measured by antithrombin-III levels.
Pryor JA; Cooper KR; Bass JD; Hampton HL; Rock WA; Morrison JC
J Miss State Med Assoc; 1996 Oct; 37(10):777-9. PubMed ID: 8908950
[TBL] [Abstract][Full Text] [Related]
20. Timing of Etonogestrel-Releasing Implants and Growth of Breastfed Infants: A Randomized Controlled Trial.
Carmo LSMP; Braga GC; Ferriani RA; Quintana SM; Vieira CS
Obstet Gynecol; 2017 Jul; 130(1):100-107. PubMed ID: 28594758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
